Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Chemotherapy Market Evolve in Terms of Growth and Size by 2029?

In the past few years, the chemotherapy market has experienced robust growth. It is projected to grow from $34 billion in 2024, soaring to $37.27 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. Factors contributing to the growth during the historic period include increased cancer occurrences, advancements in cancer detection procedures, innovative drug development, clinical trial activity, improved healthcare access, and awareness campaigns.

The market size of chemotherapy is predicted to experience accelerated growth in the forthcoming years, increasing to $60.31 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 12.8%. The predicted growth during the forecast period can be credited to the incorporation of immunotherapy, adoption of biosimilars, expansion of emerging markets, genomic profiling, enhancements in supportive care, and regulatory facilitation. Significant trends anticipated during the forecast period include the use of digital health solutions, personalized medicine, persistent oncology research, assimilation of AI, progress in nanotechnology, and home-based chemotherapy administration.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

What factors are expected to fuel Chemotherapy market growth in the coming years?

The growth of the chemotherapy market is anticipated to be propelled by the escalating prevalence of cancer. Cancer is a condition where certain cells in the body grow uncontrollably and spread elsewhere. Chemotherapy involves the use of potent chemicals, either singularly or in a combination, to treat cancer by destroying rapidly growing cancer cells. This upward trend in the incidence of cancer is likely to spur the demand for chemotherapy. For example, the American Cancer Society Inc., a not-for-profit health organization based in America, predicts that the number of newly diagnosed cancer cases will rise to 1.9 million in 2023, compared to 1.8 million in 2020. Moreover, it is projected that by 2023, the number of cancer-related deaths will reach 609,820 in the US, rising from 606,520 in 2020. Consequently, the rising incidence of cancer is the driving force behind the expanding chemotherapy market.

What Are The Key Findings From The Segmentation Analysis Of The Chemotherapy Market?

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

Which Trends Are Expected To Shape The Future Of The Chemotherapy Market?

Key players in the chemotherapy market are aiming to set themselves apart through the introduction of inventive products such as chemotherapy infusion pumps. These particular devices administer chemotherapy drugs directly into the blood via an intravenous line. The aim is to manage chemotherapy administration in a managed, slow and steady way, permitting a continuous and gradual drug infusion to the patient. One example is Shanghai MicroPort Lifesciences Co. Ltd., a Chinese medical technology producer; in March 2022, they were granted marketing approval from the National Medical Products Administration (NMPA) in China for their AutoEx Chemotherapy Infusion Pump. The AutoEx is engineered to either continuously or intermittently infuse chemotherapy drugs into patients dealing with malignancies. The ultimate goal is to maintain an ideal drug concentration in the patient’s bloodstream, which optimises the success of the cancer treatment and minimizes side effects. The pump is designed with a dual CPU control system and a backup power supply, allowing for outstanding precision in drug delivery – improving patient comfort and safety throughout chemotherapy.

What Are The Most Active Companies In The Chemotherapy Market Today?

Major companies operating in the chemotherapy market include GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Which Regional Markets Are Attracting The Most Investment In Chemotherapy?

North America was the largest region in the chemotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9219&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model